COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics

In September 2021, federal leadership and key stakeholders came together for a virtual workshop hosted by the FDA to review the recommendations to enhance the scoping, prioritization, and communication of research activities within the context of a public health emergency. This report, COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics, provides a summary of the virtual workshop discussions and identification of lessons learned during the first year of the COVID-19 Pandemic.